SCHEMBL20565161

SCHEMBL20565161

COc1nc(COC2(C(=O)N3CCOc4c(C#N)cncc4C3)CCNCC2)c(F)cc1F

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21868460 0.82 RIPK1 (0.68) RIPK1
SCHEMBL20565160 0.81 RIPK1 (0.67) RIPK1
SCHEMBL31111333 0.81 RIPK1 (0.67) RIPK1
SCHEMBL21867453 0.76 RIPK1 (0.69) RIPK1
SCHEMBL29385370 0.76 RIPK1 (0.69) RIPK1
SCHEMBL21867720 0.76 RIPK1 (0.70) RIPK1
SCHEMBL21868468 0.75 RIPK1 (0.87) RIPK1
Hydrochloric Acid SCHEMBL21800551 0.75 RIPK1 (0.68) RIPK1
SCHEMBL21868470 0.74 RIPK1 (0.62) RIPK1
SCHEMBL21868505 0.74 RIPK1 (0.79) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3624797-A1 KINASE INHIBITORS AND USES THEREOF Denali Therapeutics Inc. (US) 2020-03-25 EP disclosed
WO-2018213632-A1 KINASE INHIBITORS AND USES THEREOF DENALI THERAPEUTICS INC. (US) 2018-11-22 WO disclosed